Global Nucleic Acid Testing Market 2016-2020

  • ID: 3985285
  • Report
  • Region: Global
  • 79 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Acon Laboratories
  • Ahram Biosystem
  • Biocartis
  • Cepheid
  • EKF Diagnostics
  • MORE
About Nucleic Acid Testing

Nucleic acid testing (NAT) is the process involved in the detection of viral DNAs and RNAs in blood samples of individuals. NAT or nucleic acid amplification test (NAAT) is one of the fastest growing segments in the in-vitro diagnostics market (IVD). There are different types of NAT techniques such as Polymerase chain reaction (PCR), Strand displacement amplification (SDA), Ligase chain reaction (LCR), Transcription-mediated amplification (TMA), Nucleic acid sequence based amplification (NASBA) and whole genome sequencing.

The analysts forecast the global nucleic acid testing market to grow at a CAGR of 9.96% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global nucleic acid testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top vendors operating in the market.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Nucleic Acid Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Roche Molecular Systems
- Siemens Healthineers
- Hologic
- Qiagen

Other prominent vendors
- Accriva Diagnostics
- Acon Laboratories
- Affymetrix
- Ahram Biosystem
- Asuragen
- Biocartis
- Bio-Rad Laboratories
- Cepheid
- DiagCor
- EKF Diagnostics
- Erba Diagnostics
- Randox Laboratories

Market drivers
- Higher adoption rate of molecular point-of-care (POC) testing.
- For a full, detailed list, view the full report

Market challenges
- Risks associated with molecular diagnosis.
- For a full, detailed list, view the full report

Market trends
- Advances in precision and personalized medicine.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Acon Laboratories
  • Ahram Biosystem
  • Biocartis
  • Cepheid
  • EKF Diagnostics
  • MORE
Part 01: Executive summary
  • Highlights
Part 02: Scope of the report
  • Market overview
  • Top-vendor offerings
Part 03: Market research methodology
  • Research methodology
  • Economic indicators
Part 04: Introduction
  • Key market highlights
Part 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Market segmentation by product
  • Instruments
  • Reagents
Part 07: Market segmentation by indication
  • Market overview
  • Infectious diseases
  • Cancer
  • Genetics
Part 08: Market segmentation by technology
  • Polymerase chain reaction (PCR)
  • Strand displacement amplification (SDA)
  • Ligase chain reaction (LCR)
  • Others
Part 09: Market segmentation by end-users
  • Hospitals
  • Clinics
  • Research institutes
Part 10: Geographical segmentation
  • Nucleic acid testing market in Americas
  • Nucleic acid testing market in the EMEA
  • Nucleic acid testing market in the APAC
Part 11: Market drivers
  • Genome engineering and gene editing on rise
  • Higher adoption rate of molecular point-of-care (POC) testing
  • Improved sensitivity for the detection systems
Part 12: Impact of drivers

Part 13: Market challenges
  • High cost of equipment and reagents
  • Stringent regulatory framework
  • Risks associated with molecular diagnosis
Part 14: Impact of drivers and challenges

Part 15: Market trends
  • Next generation sequencing
  • Higher adoption rate for NAT
  • Advances in precision and personalized medicine
Part 16: Vendor landscape
  • Competitive scenario
Part 17: Key vendor analysis
  • Abbott Laboratories
  • Roche Molecular Systems
  • Siemens Healthineers
  • Hologic
  • Qiagen
  • Key Companies to watch
  • Other prominent vendors
Part 18: Appendix
  • List of abbreviations
Part 19: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global nucleic acid testing market 2015-2020 ($ billions)
Exhibit 03: Global nucleic acid testing market diversification
Exhibit 04: Impact assessment for global nucleic acid testing market
Exhibit 05: Five forces analysis
Exhibit 06: Global nucleic acid testing market by product 2015-2020 (%)
Exhibit 07: Global nucleic acid testing market segmentation
Exhibit 08: Global nucleic acid testing market by indication 2015-2020 (%)
Exhibit 09: NAT tests for infectious diseases
Exhibit 10: Nucleic acid testing market by indication - infectious diseases 2015-2020 ($ billion)
Exhibit 11: Nucleic acid testing market by indication - cancer 2015-2020 ($ billions)
Exhibit 12: Nucleic acid testing market by indication - genetics 2015-2020 ($ billions)
Exhibit 13: Global nucleic acid testing market by technology 2015-2020 (%)
Exhibit 14: Market strategy analysis of PCR technology
Exhibit 15: Market dynamics of PCR technology
Exhibit 16: Market strategy analysis of SDA technology
Exhibit 17: Market dynamics of SDA technology
Exhibit 18: Market strategy analysis of LCR technology
Exhibit 19: Market dynamics of LCR technology
Exhibit 20: Global nucleic acid testing market by end-users 2015-2020 (%)
Exhibit 21: Market overview of nucleic acid testing in Americas
Exhibit 22: Nucleic acid testing market in Americas 2015-2020 ($ billions)
Exhibit 23: Market overview of nucleic acid testing in EMEA
Exhibit 24: Nucleic acid testing market in EMEA 2015-2020 ($ billions)
Exhibit 25: Market overview of nucleic acid testing in APAC
Exhibit 26: Nucleic acid testing market in APAC 2015-2020 ($ billions)
Exhibit 27: Impact of drivers
Exhibit 28: Market impact of regulatory policies in different countries
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Common methods in next generation sequencing
Exhibit 31: Key application areas of next generation sequencing technology
Exhibit 32: Comparison between NAT and serological blood screening
Exhibit 33: Features and benefits of personalized medicines - Market impact
Exhibit 34: Competitive structure analysis of global nucleic acid testing market 2015
Exhibit 35: Market penetration of global nucleic acid testing manufacturers (2015)
Exhibit 36: Strategic success factors of companies in global nucleic acid testing market
Exhibit 37: Abbott Laboratories strength assessment
Exhibit 38: Abbott Laboratories strategy assessment
Exhibit 39: Abbott Laboratories opportunity assessment
Exhibit 40: Roche Molecular Systems strength assessment
Exhibit 41: Roche Molecular Systems strategy assessment
Exhibit 42: Roche Molecular Systems: Opportunity assessment
Exhibit 43: Siemens Healthineers strength assessment
Exhibit 44: Siemens Healthineers strategy assessment
Exhibit 45: Siemens Healthineers: Opportunity assessment
Exhibit 46: Hologic strength assessment
Exhibit 47: Hologic strategy assessment
Exhibit 48: Hologic: Opportunity assessment
Exhibit 49: Qiagen strength assessment
Exhibit 50: Qiagen strategy assessment
Exhibit 51: Qiagen: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Acon Laboratories
  • Ahram Biosystem
  • Biocartis
  • Cepheid
  • EKF Diagnostics
  • MORE
New Report Released: - Global Nucleic Acid Testing Market 2016-2020

The author of the report recognizes the following companies as the key players in the global nucleic acid testing market: Abbott Laboratories, Roche Molecular Systems, Siemens Healthineers, Hologic, and Qiagen.

Other prominent vendors in the market are: Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, Asuragen, Biocartis, Bio-Rad Laboratories, Cepheid, DiagCor, EKF Diagnostics, Erba Diagnostics, and Randox Laboratories.

Commenting on the report, an analyst from the research team said: “One of latest trends in the market is next generation sequencing. Next generation sequencing (NGS) is the game changing trend in the IVD market due to its wide range of methods being readily available to the researchers. This sequencing method helps in answering any question about the genome, epitome and transcriptome of an organism. The process of sequencing has emerged as a technology boom for the clinical diagnosis field. It enables doctors and researchers in the detection of various infectious diseases such as Chlamydia trachomatis/Neisseria gonorrhoeae infection and pulmonary tuberculosis. Some of the most common NGS methods trending in the molecular diagnosis field are exome sequencing, total RNA and mRNA sequencing.”

According to the report, one of the primary drivers in the market is genome engineering and gene editing on rise. Genome engineering is one of the new technologies in the IVD market, which is gaining quick acceptance and serve beneficial in transforming healthcare system. Genome sequencing in molecular diagnostics helps in the detection of most complex diseases such as cancer and HIV. The next generation sequencing is one of the lucrative investments for pharmaceutical companies. The market is witnessing higher investment in the genomics research, government funding for gene therapy and other related techniques. There is a rise in the demand for gene editing for the alteration of genetic framework of an organism. This helps in facilitating the removal of defective gene and infusing corrective one resuming the genetic framework of body. With the use of technologies such as CRISPR and antisense technology, the researchers aim to change the prevailing healthcare scenario. Along with the improvement in blood screening process through NAT, the researchers aim to use the technology of gene editing for the treatment of incurable diseases such as HIV and cancer.

Further, the report states that one major challenge in the market is risks associated with molecular diagnosis. With the advent of new technologies in the market, the process of clinical diagnostics has undergone a transformation. The NAT blood screening process has served beneficial in determining infectious agents. However, the molecular diagnosis process involved in the screening of infectious diseases and genetic variation have some risks associated with it. The standardization of the system makes the process of optimization a tedious task. But, it plays a key role in maintaining the accuracy of results. The diagnostic systems lack the feature for determining sample type and volume. This acts a constraint in development of efficient NAT screening systems and integration of systems. There is a lack in the integration of diagnostic assays along with the next generation screening systems. The improved sensory system for biosensors is an unmet demand of the molecular diagnostics. The sensitivity for biosensors will ensure accuracy and eliminate enzymatic in-vitro amplification process. These risks divert the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Roche Molecular Systems
  • Siemens Healthineers
  • Hologic
  • Qiagen
  • Accriva Diagnostics
  • Acon Laboratories
  • Affymetrix
  • Ahram Biosystem
  • Asuragen
  • Biocartis
  • Bio-Rad Laboratories
  • Cepheid
  • DiagCor
  • EKF Diagnostics
  • Erba Diagnostics
  • Randox Laboratories
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll